Caliber opens new TX manufacturing facility

Caliber Biotherapeutics has opened the world's largest plant-made pharmaceutical manufacturing facility in its base, Bryan, TX. The company is also planning to develop cell- and microbial-based production systems to enhance its cancer and infectious disease pipeline. The new plant can produce up to 100 million vaccine doses and hundreds of thousands of protein biotherapeutics per month.

"The Caliber platform is designed to be uniquely agile and responsive, enabling us to accelerate development of products with improved efficacy, reduced cost and enhanced safety," said Dr. Brett Giroir, Chief Medical Officer, in a release. "Our goal is to make a rapid, meaningful impact on patients with unmet medical needs, both in the United States as well as in lesser developed countries with profound public health challenges."

- see the Caliber release

Suggested Articles

Novavax will have billions of doses of COVID-19 vaccine capacity next year and could single-handedly meet U.S. demand, executives said.

As top players race to deliver COVID-19 vaccines, Russia approved a locally developed shot based on skimpy data. Experts called it a political stunt.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan